oxophenylarsine has been researched along with Angiogenesis, Pathologic in 1 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Don, AS | 1 |
| Kisker, O | 1 |
| Dilda, P | 1 |
| Donoghue, N | 1 |
| Zhao, X | 1 |
| Decollogne, S | 1 |
| Creighton, B | 1 |
| Flynn, E | 1 |
| Folkman, J | 1 |
| Hogg, PJ | 1 |
1 other study available for oxophenylarsine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells.
Topics: Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Adenosine Triphosphate; Angiogenesis Inhib | 2003 |